Angelini SPA has unveiled initial plans to grow its ThermaCare brand after closing its acquisition of the global rights, excluding North America, to the OTC pain-relief line from GSK Consumer Healthcare.
Looking to hit the ground running, the Italian company has signed a distribution deal for ThermaCare covering the Netherlands and the Nordic region, and separately will establish a direct presence in Germany for the first time to market the brand. Annoucing the acquisition of ThermaCare last month, Angelini described the brand as a “coveted and successful” consumer health product
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?